GlassScriptPhysician profile
Kelli M Lamb
NPI 1427394345
$9,547.24
in general payments reported to CMS, 2019-2025
33 companies · $3,227 in 2025
The $3,227 reported for 2025 was more than what 96% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $1,262 · 2023: $2,144 · 2024: $2,726 · 2025: $3,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,003 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,003.16 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,492.52 | 2022-2025 | |
| Janssen Biotech, INC. | $1,474.59 | 2022-2025 | Stelara, Tremfya, Remicade |
| Madrigal Pharmaceuticals | $755.61 | 2024-2025 | Rezdiffra, Resmetirom |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $659.16 | 2022-2025 | Xifaxan, Trulance, Plenvu |
| Phathom Pharmaceuticals, INC. | $509.81 | 2024-2025 | Voquezna |
| Genzyme Corporation | $473.91 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $432.55 | 2022-2025 | Entyvio, Eohilia, Gattex |
| Regeneron Healthcare Solutions, INC. | $355.87 | 2023-2025 | Dupixent |
| Lilly USA, LLC | $328.87 | 2023-2025 | Omvoh |
| Aimmune Therapeutics, INC. | $311.68 | 2024-2025 | Zenpep |
| Ironwood Pharmaceuticals, INC | $289.74 | 2022-2025 | Linzess |
| Ardelyx, INC. | $202.47 | 2023-2025 | Ibsrela |
| Celgene Corporation | $168.11 | 2022-2024 | Zeposia |
| Bard Peripheral Vascular, INC. | $127.75 | 2021 | |
| Daiichi Sankyo INC. | $96.20 | 2022-2023 | Injectafer |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $87.81 | 2022-2024 | Dificid, Zinplava |
| Celltrion USA INC. | $84.16 | 2024-2025 | Vegzelma, Zymfentra |
| Redhill Biopharma INC. | $80.62 | 2022 | |
| Qol Medical, LLC | $71.56 | 2022 | |
| Mallinckrodt Hospital Products INC. | $67.61 | 2022-2023 | Terlivaz |
| Braintree Laboratories, INC. | $61.26 | 2022-2023 | Suflave, Sutab |
| Pfizer INC. | $53.99 | 2023-2025 | |
| Gilead Sciences, INC. | $46.18 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $44.71 | 2023-2024 | Givlaari |
| Intercept Pharmaceuticals, INC. | $44.12 | 2022-2024 | |
| Amgen INC. | $41.23 | 2025 | Uplizna |
| Nestle Healthcare Nutrition INC. | $38.28 | 2023 | |
| Novartis Pharmaceuticals Corporation | $37.06 | 2021 | |
| Pharmacosmos Therapeutics INC. | $28.32 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.65 | 2021 | |
| Mirum Pharmaceuticals, INC. | $24.56 | 2024 | Livmarli |
| Organon LLC | $19.47 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Lamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.